FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386965128> ?p ?o ?g. }

• W4386965128 endingPage "6349" @default.
• W4386965128 startingPage "6339" @default.
• W4386965128 abstract "This study reports the vaccine effectiveness (VE) of COVID-19 vaccine regimens in the United States, based on the National COVID Cohort Collaborative (N3C) database.Data from 10.4 million adults, enrolled in the N3C from 11 December 2020 to 30 June 2022, were analyzed. VE against infection and death outcomes were evaluated across 13 vaccine regimens in recipient cohorts during the Pre-Delta, Delta, and Omicron periods. VE was estimated as (1-odds ratio) × 100% by multivariate logistic regression, using the unvaccinated cohort as reference.Natural immunity showed a highly protective effect (70.33%) against re-infection, but the mortality risk among the unvaccinated population was increased after re-infection; vaccination following infection reduced the risk of re-infection and death. mRNA-1273 full vaccination plus mRNA-1273 booster showed the highest anti-infection effectiveness (47.59%) (95% CI, 46.72-48.45) in the overall cohort. In the type 2 diabetes cohort, VE against infection was highest with BNT162b2 full vaccination plus mRNA-1273 booster (61.19%) (95% CI, 53.73-67.75). VE against death was also highest with BNT162b2 full vaccination plus mRNA-1273 booster (89.56%) (95% CI, 85.75-92.61). During the Pre-Delta period, all vaccination regimens showed an anti-infection effect; during the Delta period, only boosters, mixed vaccines, and Ad26.COV2.S vaccination exhibited an anti-infection effect; during the Omicron period, none of the vaccine regimens demonstrated an anti-infection effect. Irrespective of the variant period, even a single dose of mRNA vaccine offered protection against death, thus demonstrating survival benefit, even in the presence of infection or re-infection. Similar patterns were observed in patients with type 2 diabetes.Although the anti-infection effect declined as SARS-CoV-2 variants evolved, all COVID-19 mRNA vaccines had sustained effectiveness against death. Vaccination was crucial for preventing re-infection and reducing the risk of death following SARS-CoV-2 infection." @default.
• W4386965128 created "2023-09-23" @default.
• W4386965128 creator A5001855236 @default.
• W4386965128 creator A5010978891 @default.
• W4386965128 creator A5024200175 @default.
• W4386965128 creator A5042435594 @default.
• W4386965128 creator A5055845969 @default.
• W4386965128 creator A5056724113 @default.
• W4386965128 creator A5061079851 @default.
• W4386965128 creator A5066725965 @default.
• W4386965128 creator A5069789255 @default.
• W4386965128 creator A5083009855 @default.
• W4386965128 date "2023-10-01" @default.
• W4386965128 modified "2023-10-15" @default.
• W4386965128 title "Effectiveness of various COVID-19 vaccine regimens among 10.4 million patients from the National COVID Cohort Collaborative during Pre-Delta to Omicron periods – United States, 11 December 2020 to 30 June 2022" @default.
• W4386965128 cites W2774743973 @default.
• W4386965128 cites W3049452588 @default.
• W4386965128 cites W3111255098 @default.
• W4386965128 cites W3120576719 @default.
• W4386965128 cites W3165046644 @default.
• W4386965128 cites W3193039013 @default.
• W4386965128 cites W4200487669 @default.
• W4386965128 cites W4200498553 @default.
• W4386965128 cites W4205483821 @default.
• W4386965128 cites W4211043735 @default.
• W4386965128 cites W4211242522 @default.
• W4386965128 cites W4225327633 @default.
• W4386965128 cites W4225574157 @default.
• W4386965128 cites W4280579751 @default.
• W4386965128 cites W4293652697 @default.
• W4386965128 cites W4293724003 @default.
• W4386965128 cites W4297242649 @default.
• W4386965128 cites W4319461286 @default.
• W4386965128 doi "https://doi.org/10.1016/j.vaccine.2023.08.069" @default.
• W4386965128 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37741761" @default.
• W4386965128 hasPublicationYear "2023" @default.
• W4386965128 type Work @default.
• W4386965128 citedByCount "0" @default.
• W4386965128 crossrefType "journal-article" @default.
• W4386965128 hasAuthorship W4386965128A5001855236 @default.
• W4386965128 hasAuthorship W4386965128A5010978891 @default.
• W4386965128 hasAuthorship W4386965128A5024200175 @default.
• W4386965128 hasAuthorship W4386965128A5042435594 @default.
• W4386965128 hasAuthorship W4386965128A5055845969 @default.
• W4386965128 hasAuthorship W4386965128A5056724113 @default.
• W4386965128 hasAuthorship W4386965128A5061079851 @default.
• W4386965128 hasAuthorship W4386965128A5066725965 @default.
• W4386965128 hasAuthorship W4386965128A5069789255 @default.
• W4386965128 hasAuthorship W4386965128A5083009855 @default.
• W4386965128 hasConcept C121332964 @default.
• W4386965128 hasConcept C12590561 @default.
• W4386965128 hasConcept C126322002 @default.
• W4386965128 hasConcept C1276947 @default.
• W4386965128 hasConcept C151956035 @default.
• W4386965128 hasConcept C156957248 @default.
• W4386965128 hasConcept C203014093 @default.
• W4386965128 hasConcept C203165030 @default.
• W4386965128 hasConcept C22070199 @default.
• W4386965128 hasConcept C2780801004 @default.
• W4386965128 hasConcept C2908647359 @default.
• W4386965128 hasConcept C71924100 @default.
• W4386965128 hasConcept C72563966 @default.
• W4386965128 hasConcept C8891405 @default.
• W4386965128 hasConcept C99454951 @default.
• W4386965128 hasConceptScore W4386965128C121332964 @default.
• W4386965128 hasConceptScore W4386965128C12590561 @default.
• W4386965128 hasConceptScore W4386965128C126322002 @default.
• W4386965128 hasConceptScore W4386965128C1276947 @default.
• W4386965128 hasConceptScore W4386965128C151956035 @default.
• W4386965128 hasConceptScore W4386965128C156957248 @default.
• W4386965128 hasConceptScore W4386965128C203014093 @default.
• W4386965128 hasConceptScore W4386965128C203165030 @default.
• W4386965128 hasConceptScore W4386965128C22070199 @default.
• W4386965128 hasConceptScore W4386965128C2780801004 @default.
• W4386965128 hasConceptScore W4386965128C2908647359 @default.
• W4386965128 hasConceptScore W4386965128C71924100 @default.
• W4386965128 hasConceptScore W4386965128C72563966 @default.
• W4386965128 hasConceptScore W4386965128C8891405 @default.
• W4386965128 hasConceptScore W4386965128C99454951 @default.
• W4386965128 hasFunder F4320332161 @default.
• W4386965128 hasFunder F4320337472 @default.
• W4386965128 hasIssue "42" @default.
• W4386965128 hasLocation W43869651281 @default.
• W4386965128 hasLocation W43869651282 @default.
• W4386965128 hasOpenAccess W4386965128 @default.
• W4386965128 hasPrimaryLocation W43869651281 @default.
• W4386965128 hasRelatedWork W2324037830 @default.
• W4386965128 hasRelatedWork W2385876451 @default.
• W4386965128 hasRelatedWork W3201177512 @default.
• W4386965128 hasRelatedWork W4200574689 @default.
• W4386965128 hasRelatedWork W4223961516 @default.
• W4386965128 hasRelatedWork W4283826450 @default.
• W4386965128 hasRelatedWork W4291949795 @default.
• W4386965128 hasRelatedWork W4302774475 @default.
• W4386965128 hasRelatedWork W4309690816 @default.
• W4386965128 hasRelatedWork W4311793641 @default.
• W4386965128 hasVolume "41" @default.
• W4386965128 isParatext "false" @default.

• next